WEDBUSH SECURITIES INC
Broker-DealerPosition in LGND — Ligand Pharmaceuticals Inc
CIK 1142495
PASADENA, CA
Position in LGND
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$341,693
+$125,473 QoQ
Shares Held
1,081
-0.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#273
of 413 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WEDBUSH SECURITIES INC holds $4,116,162 across 9 Biotechnology names. LGND ranks #3 (8.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,745 | $2,356,983 | |
| 2 | IOVA |
Iovance Biotherapeutics, Inc.
|
145,473 | $605,167 | |
| 3 | LGND |
Ligand Pharmaceuticals Inc
This page
|
1,081 | $341,693 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
1,548 | $289,909 | |
| 5 | SNDX |
Syndax Pharmaceuticals Inc
|
12,705 | $277,731 | |
| 6 | RNAC |
Cartesian Therapeutics, Inc.
|
10,500 | $109,410 | |
| 7 | LXRX |
Lexicon Pharmaceuticals, Inc.
|
20,000 | $48,000 | |
| 8 | GERN |
Geron Corp
|
34,898 | $44,669 |
All Filings in LGND
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $341,693 | 1,081 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $216,220 | 1,083 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $204,762 | 1,083 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $200,699 | 1,133 | Shares | Sole | 2025-11-06 | |
| No filing history on record for this holder in this stock. | ||||||